Design, Synthesis, and Pharmacological Evaluation of Piperazine Hydrazide Derivatives as Potential CNS-Active Antidepressants: MAO-A Inhibition and In Silico Docking Studies on Protein 2BXR and N1 Neuraminidase (PDB 2HU4) for Alzheimer's Disease
DOI:
https://doi.org/10.48047/CU/54/02/1594-1611Keywords:
Molecular docking, blood-brain barrier, forced swimming test, antidepressant, piperazine-substituted oxadiazoles, and drug-like characteristics.Abstract
Since piperazine-substituted oxadiazoles have the potential to be kinase inhibitors, antibacterial agents, and medications that target the central nervous system (CNS), their synthesis and evaluation have attracted a lot of attention. In this work, six novel piperazine-oxadiazole derivatives (VSM 1–VSM 6) are designed, synthesised, and biologically evaluated. The compounds were created via condensation processes, hydrazinolysis, and nucleophilic substitution, producing stable heterocyclic structures. Extensive molecular docking studies and spectrum analysis (IR, NMR) were conducted, and in silico predictions suggested promising drug-like qualities. The substances demonstrated minimal toxicity, high oral bioavailability, and blood-brain barrier (BBB) penetration.
Downloads
References
Lombardino, J.G. and Lowe III, J.A. (2004) The role of the medicinal chemist in drug discovery—then and now. Nature Reviews Drug Discovery 3 (10), 853-862
Hu, W. et al. (2018) Discovery of novel topoisomerase II inhibitors by medicinal chemistry approaches. Journal of Medicinal Chemistry 61 (20), 8947-8980
Müller, G. (2003) Medicinal chemistry of target family-directed masterkeys. Drug Discovery Today 8 (15), 681-691
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
